Register and share your invite link to earn from video plays and referrals.

Search results for IAM
IAM community
One keyword maps to one global community path.
Create community
People
Not Found
Tweets including IAM
.@iamluckydaye is trusting his team to help push his story forward. In a new Billboard News interview, he opens up about his latest album ‘ALOUD,’ how a sabbatical in Brazil shaped its sound and the inspiration behind songs like “Nowhere Fast” and “Fly U Out” and so much more.
Show more
.@iamluckydaye is thinking about the legacy he wants to leave with his music. In a new Billboard News interview, he opens up about his latest album ‘ALOUD,’ how a sabbatical in Brazil shaped its sound and the inspiration behind songs like “Nowhere Fast” and “Fly U Out.”
Show more
@iammayorkun live at the wedding celebration of Zlatan Ibile and Davita as they celebrate their love and begin a beautiful new chapter together. 💍❤️✨ 📍 Lekki, Lagos For event coverage, send us a DM or email: instablog9jaevents@gmail.com #ZlatanIbile# #Davita# #ZlatanAndDavita# #WeddingCelebration# #Instablog9jaEventCoverage# #InstablogEvent#
Show more
.@iambic_ai is pursuing a fundamental shift in the biopharmaceutical industry through molecular superintelligence. Now, that vision comes to the public markets under the ticker $IAM. #NasdaqListed#
Show more
Iambic Therapeutics shares soared 16% in its trading debut after the clinical-stage cancer drugmaker and technology firm raised $150 million in a US initial public offering
IAMBIC SHARES SOAR 16% IN THEIR NASDAQ DEBUT The clinical-stage cancer drugmaker and technology firm priced its $150 million IPO at $16 a share, per Bloomberg and Nasdaq
.@iambic_ai is advancing better technology for better medicines by integrating proprietary, large-scale AI with automated, scalable chemistry and biology experimentation. Welcome to Nasdaq, $IAM! #NasdaqListed#
Show more
IAMBIC RAISES $150 MILLION IN ITS US IPO The Nvidia-backed AI drugmaker sold 9.375M shares and is set to trade on Nasdaq under the ticker IAM, per Bloomberg and SEC filings
Iambic, a clinical-stage cancer drugmaker and technology firm, raised $150 million in a US IPO that priced at the midpoint of its marketed range
@iamSarahLace is “My Naughty Nurse”that came by to give that thorough physical therapy session